ID   CDKL3_HUMAN             Reviewed;         592 AA.
AC   Q8IVW4; D3DQA0; D3DQA1; Q9P114;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   12-OCT-2022, entry version 172.
DE   RecName: Full=Cyclin-dependent kinase-like 3 {ECO:0000305};
DE            EC=2.7.11.22;
DE   AltName: Full=Serine/threonine-protein kinase NKIAMRE;
GN   Name=CDKL3 {ECO:0000312|HGNC:HGNC:15483};
GN   Synonyms=NKIAMRE {ECO:0000303|Ref.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Fetal heart;
RA   Midmer M., Haq R., Zanke B.W.;
RT   "NKIAMRE a novel kinase deleted in human leukemia.";
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0007744|PDB:3ZDU}
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 1-324 IN COMPLEX WITH SYNTHETIC
RP   INHIBITOR.
RX   PubMed=29420175; DOI=10.1016/j.celrep.2017.12.083;
RA   Canning P., Park K., Goncalves J., Li C., Howard C.J., Sharpe T.D.,
RA   Holt L.J., Pelletier L., Bullock A.N., Leroux M.R.;
RT   "CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary
RT   Function.";
RL   Cell Rep. 22:885-894(2018).
RN   [5]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-394.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.22;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.22;
CC   -!- INTERACTION:
CC       Q8IVW4; Q8WYN0: ATG4A; NbExp=3; IntAct=EBI-3919850, EBI-3044060;
CC       Q8IVW4; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-3919850, EBI-3867333;
CC       Q8IVW4; Q9NRI5-2: DISC1; NbExp=3; IntAct=EBI-3919850, EBI-11988027;
CC       Q8IVW4; Q9NQM4: DNAAF6; NbExp=3; IntAct=EBI-3919850, EBI-10239299;
CC       Q8IVW4; P51114-2: FXR1; NbExp=3; IntAct=EBI-3919850, EBI-11022345;
CC       Q8IVW4; P51116: FXR2; NbExp=7; IntAct=EBI-3919850, EBI-740459;
CC       Q8IVW4; Q08379: GOLGA2; NbExp=3; IntAct=EBI-3919850, EBI-618309;
CC       Q8IVW4; Q13422-7: IKZF1; NbExp=3; IntAct=EBI-3919850, EBI-11522367;
CC       Q8IVW4; Q63ZY3: KANK2; NbExp=3; IntAct=EBI-3919850, EBI-2556193;
CC       Q8IVW4; Q8N6L0: KASH5; NbExp=3; IntAct=EBI-3919850, EBI-749265;
CC       Q8IVW4; P60411: KRTAP10-9; NbExp=3; IntAct=EBI-3919850, EBI-10172052;
CC       Q8IVW4; Q9P2M1: LRP2BP; NbExp=3; IntAct=EBI-3919850, EBI-18273118;
CC       Q8IVW4; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-3919850, EBI-741037;
CC       Q8IVW4; P23508: MCC; NbExp=3; IntAct=EBI-3919850, EBI-307531;
CC       Q8IVW4; Q99750: MDFI; NbExp=3; IntAct=EBI-3919850, EBI-724076;
CC       Q8IVW4; Q5JR59: MTUS2; NbExp=3; IntAct=EBI-3919850, EBI-742948;
CC       Q8IVW4; Q5JR59-3: MTUS2; NbExp=4; IntAct=EBI-3919850, EBI-11522433;
CC       Q8IVW4; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-3919850, EBI-79165;
CC       Q8IVW4; Q8WWB5: PIH1D2; NbExp=3; IntAct=EBI-3919850, EBI-10232538;
CC       Q8IVW4; Q15276: RABEP1; NbExp=3; IntAct=EBI-3919850, EBI-447043;
CC       Q8IVW4; P14373: TRIM27; NbExp=6; IntAct=EBI-3919850, EBI-719493;
CC       Q8IVW4; O94972: TRIM37; NbExp=3; IntAct=EBI-3919850, EBI-741602;
CC       Q8IVW4; O43829: ZBTB14; NbExp=3; IntAct=EBI-3919850, EBI-10176632;
CC       Q8IVW4; O43298: ZBTB43; NbExp=3; IntAct=EBI-3919850, EBI-740718;
CC       Q8IVW4; Q96BR9: ZBTB8A; NbExp=6; IntAct=EBI-3919850, EBI-742740;
CC       Q8IVW4; Q9UGI0: ZRANB1; NbExp=3; IntAct=EBI-3919850, EBI-527853;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IVW4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IVW4-2; Sequence=VSP_016148;
CC   -!- DOMAIN: The [NKR]KIAxRE motif seems to be a cyclin-binding region.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF130372; AAF36509.1; -; mRNA.
DR   EMBL; CH471062; EAW62263.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW62264.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW62265.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW62266.1; -; Genomic_DNA.
DR   EMBL; BC041799; AAH41799.1; -; mRNA.
DR   CCDS; CCDS47264.1; -. [Q8IVW4-1]
DR   CCDS; CCDS47265.1; -. [Q8IVW4-2]
DR   RefSeq; NP_001107047.1; NM_001113575.1. [Q8IVW4-1]
DR   RefSeq; NP_001287782.1; NM_001300853.1.
DR   RefSeq; NP_057592.2; NM_016508.3. [Q8IVW4-2]
DR   RefSeq; XP_016865024.1; XM_017009535.1.
DR   PDB; 3ZDU; X-ray; 2.20 A; A=1-324.
DR   PDBsum; 3ZDU; -.
DR   AlphaFoldDB; Q8IVW4; -.
DR   SMR; Q8IVW4; -.
DR   BioGRID; 119419; 56.
DR   IntAct; Q8IVW4; 61.
DR   STRING; 9606.ENSP00000265334; -.
DR   BindingDB; Q8IVW4; -.
DR   ChEMBL; CHEMBL1163117; -.
DR   DrugCentral; Q8IVW4; -.
DR   iPTMnet; Q8IVW4; -.
DR   PhosphoSitePlus; Q8IVW4; -.
DR   BioMuta; CDKL3; -.
DR   DMDM; 74762479; -.
DR   jPOST; Q8IVW4; -.
DR   MassIVE; Q8IVW4; -.
DR   MaxQB; Q8IVW4; -.
DR   PaxDb; Q8IVW4; -.
DR   PeptideAtlas; Q8IVW4; -.
DR   PRIDE; Q8IVW4; -.
DR   ProteomicsDB; 70783; -. [Q8IVW4-1]
DR   ProteomicsDB; 70784; -. [Q8IVW4-2]
DR   Antibodypedia; 2061; 203 antibodies from 28 providers.
DR   DNASU; 51265; -.
DR   Ensembl; ENST00000265334.9; ENSP00000265334.4; ENSG00000006837.12. [Q8IVW4-1]
DR   Ensembl; ENST00000523832.1; ENSP00000430496.1; ENSG00000006837.12. [Q8IVW4-2]
DR   GeneID; 51265; -.
DR   KEGG; hsa:51265; -.
DR   MANE-Select; ENST00000265334.9; ENSP00000265334.4; NM_001113575.2; NP_001107047.1.
DR   UCSC; uc003kzf.5; human. [Q8IVW4-1]
DR   CTD; 51265; -.
DR   DisGeNET; 51265; -.
DR   GeneCards; CDKL3; -.
DR   HGNC; HGNC:15483; CDKL3.
DR   HPA; ENSG00000006837; Tissue enhanced (testis).
DR   MIM; 608459; gene.
DR   neXtProt; NX_Q8IVW4; -.
DR   OpenTargets; ENSG00000006837; -.
DR   PharmGKB; PA26319; -.
DR   VEuPathDB; HostDB:ENSG00000006837; -.
DR   eggNOG; KOG0593; Eukaryota.
DR   GeneTree; ENSGT00940000161317; -.
DR   HOGENOM; CLU_000288_136_1_1; -.
DR   InParanoid; Q8IVW4; -.
DR   OMA; GMEVKQV; -.
DR   OrthoDB; 398098at2759; -.
DR   PhylomeDB; Q8IVW4; -.
DR   TreeFam; TF101031; -.
DR   PathwayCommons; Q8IVW4; -.
DR   SignaLink; Q8IVW4; -.
DR   BioGRID-ORCS; 51265; 14 hits in 1102 CRISPR screens.
DR   ChiTaRS; CDKL3; human.
DR   GenomeRNAi; 51265; -.
DR   Pharos; Q8IVW4; Tchem.
DR   PRO; PR:Q8IVW4; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q8IVW4; protein.
DR   Bgee; ENSG00000006837; Expressed in sperm and 114 other tissues.
DR   ExpressionAtlas; Q8IVW4; baseline and differential.
DR   Genevisible; Q8IVW4; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0097484; P:dendrite extension; IBA:GO_Central.
DR   GO; GO:0030517; P:negative regulation of axon extension; IBA:GO_Central.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; IBA:GO_Central.
DR   GO; GO:0036211; P:protein modification process; TAS:ProtInc.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..592
FT                   /note="Cyclin-dependent kinase-like 3"
FT                   /id="PRO_0000085820"
FT   DOMAIN          4..286
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          368..390
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          459..485
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           44..50
FT                   /note="[NKR]KIAxRE"
FT   COMPBIAS        368..382
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        466..484
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        125
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         10..18
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         33
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         158
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JM01"
FT   MOD_RES         160
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JM01"
FT   VAR_SEQ         456..592
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_016148"
FT   VARIANT         394
FT                   /note="M -> T (in dbSNP:rs35687772)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041991"
FT   CONFLICT        345
FT                   /note="K -> E (in Ref. 1; AAF36509)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..13
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   STRAND          16..23
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   TURN            24..26
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   STRAND          29..34
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           45..56
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   STRAND          65..69
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   STRAND          72..74
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   STRAND          76..80
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   STRAND          83..85
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           86..92
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           99..118
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           128..130
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   STRAND          131..133
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   STRAND          139..141
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           161..164
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           169..172
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           181..196
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           206..216
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           222..230
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           232..234
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           248..251
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           257..266
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           271..273
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           277..281
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           284..287
FT                   /evidence="ECO:0007829|PDB:3ZDU"
FT   HELIX           291..308
FT                   /evidence="ECO:0007829|PDB:3ZDU"
SQ   SEQUENCE   592 AA;  67514 MW;  2B1AF08906EB7697 CRC64;
     MEMYETLGKV GEGSYGTVMK CKHKNTGQIV AIKIFYERPE QSVNKIAMRE IKFLKQFHHE
     NLVNLIEVFR QKKKIHLVFE FIDHTVLDEL QHYCHGLESK RLRKYLFQIL RAIDYLHSNN
     IIHRDIKPEN ILVSQSGITK LCDFGFARTL AAPGDIYTDY VATRWYRAPE LVLKDTSYGK
     PVDIWALGCM IIEMATGNPY LPSSSDLDLL HKIVLKVGNL SPHLQNIFSK SPIFAGVVLP
     QVQHPKNARK KYPKLNGLLA DIVHACLQID PADRISSSDL LHHEYFTRDG FIEKFMPELK
     AKLLQEAKVN SLIKPKESSK ENELRKDERK TVYTNTLLSS SVLGKEIEKE KKPKEIKVRV
     IKVKGGRGDI SEPKKKEYEG GLGQQDANEN VHPMSPDTKL VTIEPPNPIN PSTNCNGLKE
     NPHCGGSVTM PPINLTNSNL MAANLSSNLF HPSVRLTERA KKRRTSSQSI GQVMPNSRQE
     DPGPIQSQME KGIFNERTGH SDQMANENKR KLNFSRSDRK EFHFPELPVT IQSKDTKGME
     VKQIKMLKRE SKKTESSKIP TLLNVDQNQE KQEGGDGHCE GKNLKRNRFF FW
//
